Nexgel (NXGLW) Capital Leases (2024 - 2025)
Nexgel's (NXGLW) quarterly Capital Leases came in at $242000.0 in Q4 2025, down 21.17% YoY from $307000.0 in Q4 2024, and down 6.56% on a QoQ basis from $259000.0 in Q3 2025.
Nexgel (NXGLW) Capital Leases (2024 - 2025) Analysis & Trends
Nexgel (NXGLW) has 2 years of Capital Leases data on file, last reported at $242000.0 in Q4 2025.
- Quarterly Capital Leases fell 21.17% year-over-year to $242000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $242000.0 (down 21.17% YoY) and the FY2025 annual result came in at $242000.0, down 21.17% from the prior year.
- Capital Leases fell to $242000.0 in Q4 2025, from $259000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $352000.0 in Q1 2024 to a low of $242000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 242,000.00 |
| Sep 30, 2025 | 259,000.00 |
| Jun 30, 2025 | 275,000.00 |
| Mar 31, 2025 | 293,000.00 |
| Dec 31, 2024 | 307,000.00 |
| Sep 30, 2024 | 323,000.00 |
| Jun 30, 2024 | 339,000.00 |
| Mar 31, 2024 | 352,000.00 |